Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Understanding PFAS in Packaging and Processing Operations

As evidence of the harmful health and environmental effects of PFAS grows, companies need to make informed decisions to limit the substances’ presence in their operations.

One of the primary uses of PFAS is as a grease barrier in food packaging.
One of the primary uses of PFAS is as a grease barrier in food packaging.
Iryna Mylinska via Getty Images

Remarkably useful and once thought inert, per- and polyfluoroalkyl substances (PFAS) pose a growing concern for consumer-packaged goods companies, prompting a need for strategic action amid new scientific findings and legislation.

PFAS have woven themselves into the fabric of packaging and processing in the decades since their invention. Their applications include as a grease barrier in food packaging, a flow agent during plastics processing, a mold release agent, and in stain resistance for everything from car interiors to carpeting.

“They were so successful that we absolutely polluted the planet with them,” explains Keith Vorst, director of the Polymer and Food Protection Consortium (PFPC) at Iowa State University.

The PFPC is one of the largest organizations of its kind in the U.S., operating out of 10 labs to conduct packaging-related analysis, including shelf-life testing, packaging development, screening for chemicals of concern, and strategizing with brands and suppliers to establish PFAS threshold levels and identify contamination sources.

Knowledge gaps on the health and environmental toll of PFAS

Researchers are still studying the health and environmental effects of PFAS, but these largely manmade substances have become widespread through decades of use.

“Everyone on the planet right now is contaminated with these chemistries. Everyone on the planet, and most animals,” Vorst says. “[Researchers are] finding them in polar bears, in virgin forests, in marine environments that are several hundred feet below [the surface], even near the ocean floor. 

PFAS can bioaccumulate in humans and is linked to various negative health effects, including decreased fertility, developmental effects or delays in children, and increased risk of some cancers, including prostate, kidney, and testicular cancers, according to the EPA.

Regulatory bodies like the FDA have worked to limit the use of more dangerous PFAS chemistries, including a phase-out of long-chain PFAS that was completed in 2016.

The problem doesn’t stop there, though. The short-chain chemistries that replaced them may be “as dangerous or even potentially more dangerous than the long-chain, depending on which researcher or which publication you look at,” Vorst says. 

   Learn about the FDA's recent actions to limit short-chain PFAS in food packaging.

Several universities are working toward PFAS elimination or removal through methods like electro-oxidation, foam fractionation, and filtration techniques. However, these solutions are still years from scaling to a degree that creates measurable impact.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report